Items where authors include "Gossec, L"

Export as [feed] Atom [feed] RSS
Number of items: 36.

Article

De Marco, G orcid.org/0000-0003-2406-161X, Zabotti, A, Baraliakos, X et al. (7 more authors) (2023) Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce. RMD Open, 9 (2). e003143. ISSN 2056-5933

Zabotti, A, De Marco, G orcid.org/0000-0003-2406-161X, Gossec, L et al. (26 more authors) (2023) EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2022) Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD Open, 8 (2). e002518. ISSN 2056-5933

Kvien, TK, Conaghan, PG orcid.org/0000-0002-3478-5665, Gossec, L et al. (8 more authors) (2022) Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long‐term Results of Two Phase III Randomized Controlled Trials. Arthritis Care & Research, 74 (5). pp. 759-767. ISSN 2151-464X

Rahman, P, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (10 more authors) (2021) Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis. Arthritis Research and Therapy, 23 (1). 190. ISSN 1478-6354

Kiltz, U, Landewé, RBM, van der Heijde, D et al. (21 more authors) (2020) Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Annals of the Rheumatic Diseases, 79 (2). pp. 193-201. ISSN 0003-4967

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Maxwell, LJ, Beaton, DE, Shea, BJ et al. (13 more authors) (2019) Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology. Journal of Rheumatology, 46 (8). pp. 1014-1020. ISSN 0315-162X

Beaton, DE, Maxwell, LJ, Shea, BJ et al. (13 more authors) (2019) Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. Journal of Rheumatology, 46 (8). pp. 1028-1035. ISSN 0315-162X

Boers, M, Beaton, DE, Shea, BJ et al. (13 more authors) (2019) OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. The Journal of rheumatology, 46 (8). jrheum.181096. pp. 1021-1027. ISSN 0315-162X

Huynh, C, Puyraimond-Zemmour, D, Maillefert, JF et al. (18 more authors) (2018) Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. Osteoarthritis and Cartilage, 26 (10). pp. 1311-1318. ISSN 1063-4584

Højgaard, P, Klokker, L, Orbai, A-M et al. (17 more authors) (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism, 47 (5). pp. 654-665. ISSN 0049-0172

Gossec, L, McGonagle, D, Korotaeva, T et al. (4 more authors) (2018) Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature. The Journal of Rheumatology, 45 (1). pp. 6-13. ISSN 0315-162X

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Desthieux, C, Granger, B, Balanescu, AR et al. (17 more authors) (2017) Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care and Research, 69 (10). pp. 1606-1611. ISSN 2151-464X

Tunis, SR, Maxwell, LJ, Graham, ID et al. (14 more authors) (2017) Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets. The Journal of Rheumatology, 44 (10). pp. 1551-1559. ISSN 0315-162X

Coates, LC orcid.org/0000-0002-4756-663X, Gossec, L, Smolen, JS et al. (5 more authors) (2017) New GRAPPA and EULAR recommendations for the management of psoriatic arthritis: process and challenges faced. Rheumatology, 56 (8). pp. 1251-1253. ISSN 1462-0324

Smolen, JS, Landewé, R, Bijlsma, J et al. (46 more authors) (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76 (6). pp. 960-977. ISSN 0003-4967

De Wit, M, Kirwan, JR, Tugwell, P et al. (20 more authors) (2017) Successful Stepwise Development of Patient Research Partnership: 14 years’ experience of actions and consequences in Outcome Measures in Rheumatology (OMERACT). The Patient, 10 (2). pp. 141-152. ISSN 1178-1653

Gudu, T, Etcheto, A, de Wit, M et al. (16 more authors) (2016) Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine, 83 (4). pp. 439-443. ISSN 1778-7254

Orbai, A-M, Mease, PJ, de Wit, M et al. (15 more authors) (2016) Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology, 43 (5). pp. 965-969. ISSN 0315-162X

Moverley, AR, Waxman, R, de Wit, M et al. (5 more authors) (2016) Development of a Flare Instrument for Use in Psoriatic Disease: A Report from the 2015 GRAPPA Annual Meeting. The Journal of Rheumatology, 43 (5). pp. 974-978. ISSN 0315-162X

Tälli, S, Etcheto, A, Fautrel, B et al. (18 more authors) (2016) Patient global assessment in psoriatic arthritis – what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. Joint Bone Spine, 83 (3). pp. 335-340. ISSN 1297-319X

Gossec, L, Smolen, JS, Ramiro, S et al. (31 more authors) (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75 (3). pp. 499-510. ISSN 0003-4967

Ramiro, S, Smolen, JS, Landewé, R et al. (7 more authors) (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the Rheumatic Diseases, 75 (3). pp. 490-498. ISSN 0003-4967

Zangi, HA, Ndosi, ME, Adams, J et al. (12 more authors) (2015) EULAR recommendations for patient education for people with inflammatory arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Gossec, L, Smolen, JS, Gaujoux-Viala, C et al. (32 more authors) (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1). pp. 4-12. ISSN 0003-4967

Conference or Workshop Item

Zabotti, A, De Marco, G orcid.org/0000-0003-2406-161X, Gossec, L et al. (6 more authors) (2022) POS1079 CLINICAL CHARACTERIZATION OF PRODROMAL AND VERY EARLY PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW FOR THE DEFINITION OF CLINICAL AND IMAGING SUSPICIOUS FEATURES FOR PROGRESSION TO PSORIATIC ARTHRITIS. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.

Kavanaugh, A, Liu, Y, Deodhar, A et al. (8 more authors) (2021) Correlations Between Reductions in Fatigue Severity and Improvements in Physical Function and Clinical Response in Patients with Psoriatic Arthritis: Results from the Phase 3 DISCOVER Program. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Coates, L, Ritchlin, C, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Kavanaugh, A, Liu, Y, Deodhar, A et al. (8 more authors) (2021) Correlations Between Reductions in Fatigue Severity and Improvements in Physical Function and Clinical Response in Patients with Psoriatic Arthritis: Results from the Phase 3 Discover Program. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Ritchlin, CT, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Ritchlin, CT, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Coates, L, Ritchlin, C, Gossec, L et al. (12 more authors) (2020) Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2020, 05-09 Nov 2021, Virtual.

Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2020) THU0580: EULAR Task Force on Gender Equity in Academic Rheumatology: Preliminary Survey Findings. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Proceedings Paper

Gossec, L, Kirkham, B, Rahman, P et al. (4 more authors) (2018) Clinically Meaningful Improvement in Health-Related Quality of Life and the Association with Disease Activity in Psoriatic Arthritis after Treatment with Guselkumab: Results from a Randomized Placebo-Controlled Phase II Clinical Trial. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

This list was generated on Sat Mar 23 19:13:31 2024 GMT.